Tirofiban improved the prognosis of scenior acute coronary syndrome patients received percutaneous coronary intervention

Chinese Critical Care Medicine

Volumn 23, Issue 12, 2011, Pages 727-730

  Zhang, Yu Xiao ^a   Lu, Cai Yi ^a   Zhou, Sheng Hua ^a   Xue, Qiao ^a   Gao, Lei ^a   Tian, Jin Wen ^a   Gao, Wei ^a   Chen, Rui ^a   Zhai, Jin Yue ^a   Li, Li Jun ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Acute coronary syndrome; Elderly; Percutaneous coronary intervention; Prognosis; Tirofiban

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TIROFIBAN;

ACUTE CORONARY SYNDROME; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; DISEASE SEVERITY; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REVASCULARIZATION; STENT THROMBOSIS; THROMBOCYTOPENIA; TREATMENT DURATION;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; TICLOPIDINE; TYROSINE;

EID: 84862917665     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2011.12.006     Document Type: Article

References (7)

1. The RESTORE investigators. Effects of platelet glycoprotein I b/I a blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Randomized efficacy study of tirofiban for outcomes and restenosis. Circulation, 1997,96:1445-1453.
2. Platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and Symptome (PRISM-PLUS) study investigators. Inhibition of the platelet glycoprotein I b/I a receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med, 1998,338:1488-1497.
3. Platelet receptor inhibition in ischemic syndrome management (PRISM) study investigators. A comparision of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med, 1998,338:1498-1505.
4. Huynh T, Piazza N, DiBattiste PM, et al. Analysis of bleeding complications associated with glycoprotein I b/I a receptors blockade in patients with high-risk acute coronary syndromes : insights from the PRISM-PLUS study. Int J Cardiol, 2005,100:73-78. (Pubitemid 40487939)